For example, the New York Stock Exchange (NYSE) and Nasdaq both maintain dedicated sections for IPOs. Nasdaq has a dedicated section called “IPO Calendar,” and the NYSE maintains an “IPO ...

Apple ( AAPL 1.80%) has moved back into the top spot as the largest company in the world by market cap. It's gone through ...

OpenAI faces a number of challenges if it pursues an initial public offering in the future, chief among them, rewriting its ...

September is a popular time for companies to go public. This month’s stock-market volatility is putting some plans on ice. Companies weighing whether to make their stock-market debuts face a ...

Pune-based PN Gadgil sold its IPO in the price band of Rs 458-480 per share with a lot size of 31 shares, which was open for bidding between September 10 and September 12. Western Carriers India ...

The outlet reports that KIOXIA would use the future funds raised from its IPO to increasing the production of cutting-edge memory as well as development of next-generation chips. The Japanese ...

Blockdaemon, a Web3 infrastructure provider, is considering pursuing an initial public offering (IPO) in 2026, according to a Sept. 19 report by Bloomberg News citing an interview with Blockdaemon ...

Cava priced its IPO at $22 per share, valuing the company at $2.5 billion. (Photo by Spencer Platt/Getty Images) When a company exceeds quarterly growth targets and raises guidance, its stock ...

the people said, asking not to be identified as the information is private. Kioxia could kick off the IPO as soon as the coming weeks, the people said.

FRANKFURT, Sept 12 (Reuters) - Springer Nature, publisher of science journal Nature and Scientific American, said on Thursday it plans an initial public offering (IPO) on the Frankfurt Stock ...

the latest sign investor appetite remains rife and will support a further burst of activity in the kingdom’s IPO market in the final months of the year. . The flour milling company plans to ...

China’s Duality Biotherapeutics has filed (PDF) paperwork for a Hong Kong IPO, seeking an undisclosed sum to power a broad pipeline of antibody-drug conjugates toward approval. The filing ...